DARNELL RATHER: Open Payments
NPI 1134682776 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 41 payments from 14 companies in 2025. Trend: 2023 $571 · 2024 $1,327 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $292 |
| Eisai Inc. | 3 | $266 |
| Abbott Laboratories | 5 | $218 |
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| Novo Nordisk Inc | 4 | $72 |
| Gilead Sciences, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $28 |
Products named: Leqembi, FREESTYLE LIBRE 3, VRAYLAR, BREZTRI, LINZESS, MAVYRET, GVOKE HYPOPEN, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
